Loading clinical trials...
Loading clinical trials...
ALTHEA: tAckLing menTal Health Cancer Patients and Their Families: Digital Solutions for bEtter cAre
The target population includes cancer patients, caregivers, family members, healthcare providers and mental health specialists, who will be the primary end-users of the Althea platform. For patients, survivors, caregivers, and family members, the sample variables include age, gender, type and stage of disease, and time since the first diagnosis. The healthcare professionals that will be involved in this study are those who attend to oncological patients, with sample variables such as age, gender, professional role, and prior experience and training in oncology or psycho-oncology.
Age
12 - No limit years
Sex
ALL
Healthy Volunteers
Yes
Centre François Baclesse
Caen, France
Saarland University
Homburg, Germany
European Institute of Oncology
Milan, Italy, Italy
National Cancer Institute
Vilnius, Lithuania
Catalan Institute of Oncology
Barcelona, Spain
Start Date
May 14, 2025
Primary Completion Date
December 31, 2026
Completion Date
December 31, 2026
Last Updated
February 18, 2026
200
ESTIMATED participants
Patients, survivors, caregivers, family members and healthcare professionals
BEHAVIORAL
Lead Sponsor
European Institute of Oncology
Collaborators
NCT06122077
NCT06420115
NCT05989022
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions